and centralized laboratory testing for clinical assessment and commercialization—Bio-Techne has the experience and expertise to offer a seamless translational biomarker development program ...

These 'translational' biomarkers can be rigorously studied in ... believed to be toxic on the basis of a particular preclinical model. Table 1 Urinary biomarkers of kidney toxicity 12,13 Full ...

(Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, today announced new translational biomarker results for exploratory endpoints from its SER-155 Phase 1b placebo ...

I am a bioinformatician working in the Cancer Biomarkers and Translational Therapeutics Teams at the Institute of Cancer Research. I work with next generation sequencing data to understand prostate ...

Because biomarkers for precision medicine and translational research are often nucleic acid based, DNA and RNA detection methods and technologies are at the forefront of this progress. Experts from ...

https://www.tipranks.com/news/the-fly/rxsight-price-target-lowered-to-43-from-66-at-needham Seres Therapeutics (MCRB) announced new translational biomarker results ...

Seres Therapeutics (MCRB) announced new translational biomarker results for exploratory endpoints from its SER-155 Phase 1b placebo-controlled study in patients undergoing allogenic stem cell ...

Our MHR expertise group develops cellular and animal models to study mechanisms, interventions, and biomarkers in metabolic diseases, and the associated complications. In preclinical research, we ...

This enables the discovery and validation of the biomarker signatures that associate with the drug efficacy profiles of individual patients, paving the way for precision cancer treatments. The team ...

NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today a publication in Clinical and Translational Science, titled ...

Ultivue, the innovation leader in tissue biomarker identification and quantification assays for translational and pathology research labs, today announced the close of a $22 Million Series C funding ...